30 Years of Documented Infrastructure
Every entry below is documented in a primary source — a published standard, government program description, regulatory filing, or peer-reviewed paper.
First Wireless Body Area Network concept published
T. G. Zimmerman's paper "Personal Area Networks" (IBM Systems Journal, 1996) — body-capacitive coupling for data transmission; body as a conductor for personal area networking.
IEEE 802.15 Task Group 6 formed
IEEE formally begins standardizing wireless body area networks — working group specifically tasked with defining communication protocols for sensors worn on, in, or near the body.
FCC allocates Medical Device Radiocommunications spectrum
402–405 MHz MICS band established — dedicated frequency band for implanted sensors to transmit data outside the body.
IEEE 802.15.6 WBAN Standard published + FCC spectrum allocation
Defines three physical layers: Narrowband (400 MHz implanted, 900 MHz, 2.4 GHz), Ultra-Wideband (3.1–10.6 GHz), and Human Body Communication. FCC allocates additional spectrum for body-worn medical devices.
DARPA ElectRx program launched
Electrical Prescriptions: nano-scale bioelectronic devices to modulate the peripheral nervous system. $78.9M program. Goal: eliminate pharmaceuticals with implanted real-time neural modulators.
IEEE 1906.1-2015 Nanoscale Communication standard
Standard defining communication at the nano-scale — molecular signaling within and between cells. Applications include nano-biosensors inside the body.
DARPA BETR and Profusa injectable biosensor funding
BETR: closed-loop photobiomodulation for wound healing. Profusa: injectable nano-biosensors that integrate with body tissue and continuously transmit metabolic data via external reader.
DARPA N3: Non-surgical neural interface using injectable nanoparticles
High-performance brain-machine interface without surgery for able-bodied individuals. Injectable nanoparticles cross the blood-brain barrier and enable neural read/write capability.
World Economic Forum: "Internet of Bodies" white paper
WEF formally describes the three-tier IoB architecture (wearables → implantables → ingestibles/neural) and calls for governance frameworks for biological data streams.
FHIR mandate: real-time health data streaming becomes mandatory
21st Century Cures Act interoperability rules take effect — FHIR becomes mandatory for health systems. Every clinical encounter becomes a structured, transmissible data record.
FDA Modernization Act: treatments can be tested on digital twins
FDA Modernization Act 2.0 authorizes computational models ("digital twins") as alternatives to animal testing. Creates legal framework for individual biological simulation.
NRO deploys 100+ AI surveillance satellites + Neuralink FDA approval
National Reconnaissance Office launches proliferated satellite constellation providing persistent AI-capable surveillance coverage. FDA approves Neuralink's first human trial.
FDA consent waiver: "minimal risk" clinical investigations without informed consent
FDA Final Rule (21 CFR 50.22, effective January 22, 2024): certain clinical investigations may proceed without informed consent if deemed "minimal risk" by the investigating institution.
Stargate AI project: $500B for biological data processing infrastructure
Joint venture announced to build AI infrastructure capable of processing large-scale biological and health data streams.
What Does "Body as a Network Node" Mean?
Your body naturally generates electromagnetic signals — your heart, your brain, your cells. That has always been true. What changed is that over the last 30 years, an entire technical infrastructure was built to capture, transmit, process, and store that biological data at population scale.
The infrastructure has four layers. Each layer was built, standardized, and deployed — with public documentation — before most people knew the conversation was happening.
The Four-Layer Stack
1 Body Layer — Wireless Body Area Networks (WBAN) Sensors on, in, and around the body — wearables, implants, smart patches — collecting biological data (heart rate, glucose, temperature, neural activity). IEEE 802.15.6 standard (2012). Body itself used as conductor in HBC mode.
2 Data Layer — FHIR Health Data Highways Biological data flows through Fast Healthcare Interoperability Resources (FHIR) — mandatory across Medicare/Medicaid since 2021. Apple Health, Google Health, Microsoft, Amazon, Oracle all connected. Real-time streaming to cloud systems.
3 AI Layer — Digital Twins & Analysis AI builds real-time computational replicas of your physiology from the collected data. FDA Modernization Act (2022) authorizes testing treatments on digital twins. $500B Stargate AI project (2025) provides the processing scale.
4 Satellite Layer — Persistent Coverage 100+ AI-capable surveillance satellites (NRO constellation, since June 2023) provide continuous coverage of any location on Earth. GPS/Galileo/GLONASS centimeter-level location syncs all layers into one coherent stream.
Each layer is independently documented. The integration is the concern.
Where Consumer Wearables Fit In
The Wearable Is the On-Ramp
Every fitness tracker, continuous glucose monitor, sleep ring, smart patch, and health app is a Tier 1 WBAN device. The WEF Internet of Bodies white paper (2020) is explicit: consumer wearables normalize the form factor, build the habit of continuous body monitoring, and establish the data pipeline — in a regulatory environment where the FDA does not classify them as medical devices. No informed consent required. No limits on who the data is shared with.
Tier 1 — Wearables & Patches
Smartwatches, fitness trackers, ECG patches, glucose monitors, sleep rings. Exist at consumer scale today. No medical device oversight. No consent required.
Tier 2 — Implantables
Cardiac pacemakers, cochlear implants, implantable glucose sensors, drug delivery systems. Some FDA-approved today. Wireless data transmission is standard.
Tier 3 — Neural Interfaces
Brain-computer interfaces. Neuralink received FDA human trial approval 2023 (first patient implanted January 2024). DARPA N3 program developed non-surgical neural interface using injectable nanoparticles.
Nano Layer — Injectable Sensors
DARPA-funded Profusa developed injectable hydrogel nano-biosensors inserted under skin with a needle — communicate oxygen and glucose data via optical reader worn on surface. Published in Science Translational Medicine.
The Core Concern
Previous surveillance monitored what you did — your communications, location, purchases. This infrastructure monitors what you are — your autonomic nervous system, your cellular metabolism, your emotional state as detectable through biofield patterns. Privacy was once about what you chose to share. Biological surveillance is about what you cannot help but broadcast. You cannot opt out of your biofield. You can decide what devices you add to it.
What You Can Do
You cannot opt out of your biofield — your body has always generated electromagnetic signals. You can decide what you add to it, and whether you feed the data pipeline voluntarily.
Don't Add to the Monitoring
Reconsider constant-wear health wearables
Fitness trackers, sleep rings, continuous glucose monitors that sync to apps are Tier 1 WBAN devices feeding the FHIR data pipeline. Know what you're feeding. If you use them: opt out of data sharing in every app setting, avoid syncing to cloud health platforms (Apple Health, Google Fit, etc.) where possible.
Audit your health apps
Any app connected to your medical records via Apple Health or Google Health API is accessing and potentially transmitting your biological data under FHIR. Review which apps have health record access. Revoke access for apps you don't actively use.
Understand what "free" health tools cost
Free genetic testing (23andMe, AncestryDNA), free health apps, free wellness tools generate revenue through biological data. The 23andMe/Regeneron agreement specifically licensed genetic data for pharmaceutical drug development. Your genome is the product.
Reduce body-worn EMF
WBAN devices operate on frequencies that are part of the same spectrum documented to have biological effects (see the EMF page). Devices worn against the skin continuously generate non-native EMF exposure in addition to their data transmission. The monitoring and the biological harm share the same infrastructure.
Understand What You're Being Sold
The wellness wearable is the normalized on-ramp
The progression from a fitness tracker to a continuous medical monitor to an implantable device to a neural interface is not a leap — it is a continuum, each step normalized by the one before it. The WEF explicitly identified consumer wearables as the normalization layer. The form factor is designed to be desirable. "Biohacking" and "longevity optimization" culture is the marketing. Understand where the on-ramp leads before you step on it.
Case Study: LifeWave Patches — A Wellness Product With an App
LifeWave sells phototherapy patches promoted as stimulating GHK-Cu, a real copper peptide involved in tissue repair. The underlying biology — photobiomodulation — is legitimate science, and DARPA's BETR program did fund related wound-healing research. LifeWave's claimed direct connection to DARPA cannot be verified in any public government database. That association is marketing, not documentation. But here is why it belongs on this page: the patches require an app. To use LifeWave's system fully — track results, follow protocols, log responses — you use their proprietary app. That app collects your self-reported biological data, usage patterns, and health responses. The patch is a physical product. The app is a data pipeline. You are not just buying a wellness tool; you are enrolling your body's responses into a company-owned dataset. This is the normalization pattern the WEF described: a desirable wellness form factor that generates continuous biological data, without the user understanding they are a data source. The mechanism may or may not work. The data collection does. → Full product analysis: Wellness Traps — LifeWave & Patches
What Actually Supports Biological Autonomy
Morning sunlight — the original biometric optimizer
10–20 minutes of direct morning sunlight within an hour of waking establishes circadian rhythm, supports melatonin and cortisol cycling, activates GHK-Cu naturally through UV exposure, and improves metabolic signaling. No subscription, no data transmission, no EMF exposure.
Sleep architecture — restore endogenous signaling
Most of what health wearables claim to optimize (recovery, metabolic function, hormone balance) is restored by consistent, dark, EMF-reduced sleep. The monitoring device doesn't create the biology — the lifestyle does.
Reduce non-native EMF — especially at night
Turn off Wi-Fi at the router overnight. Keep phone out of the bedroom. This reduces both body-worn EMF exposure and the signal environment that WBAN devices operate in. See the full EMF Action Guide.
Ground yourself in nature
Bare feet on earth restores natural frequency connection — the same mechanism grounding products claim to provide, without dirty electricity from wall outlets and without WBAN form factor normalization. Free. And yes, your biofield connects to something larger. That is the point — that connection belongs to you, not a company's server.
Technical Standards
IEEE Standard for Local and metropolitan area networks — Part 15.6: Wireless Body Area Networks. Published February 2012. Defines in-body, on-body, and off-body communication layers including Human Body Communication (HBC) mode. Standard available for purchase at ieee.org; specifications widely cited in open-access literature.
IEEE Recommended Practice for Nanoscale and Molecular Communication Framework. Published 2015. Defines standards for communication at the molecular/nanoscale, including nano-biosensors in biological tissue and graphene nano-antenna arrays. Available at ieee.org.
Federal Communications Commission rules governing the Medical Implant Communications Service (MICS) 402–405 MHz band and broader Medical Device Radiocommunications Service. Publicly accessible at ecfr.gov.
DARPA Programs (all on darpa.mil)
Bioelectronic devices using optical, acoustic, and electromagnetic strategies to modulate the peripheral nervous system at single-axon resolution. Program performers included MIT (magnetic nanoparticles), Columbia (ultrasound), Circuit Therapeutics. Status: Complete. darpa.mil/program/electrical-prescriptions
High-performance brain-machine interface for able-bodied service members without surgery, using injectable magnetoelectric nanoparticles. Read/write to 16 neural channels within 16mm³ of tissue within 50ms. darpa.mil news release, May 2019.
Closed-loop bioelectronic system using photobiomodulation to accelerate wound healing in warfighters. darpa.mil/program/bioelectronics-for-tissue-regeneration
Bhagat et al., Science Translational Medicine (2021): injectable hydrogel biosensors for continuous oxygen monitoring under the skin. DARPA/DoD funding confirmed in company publications and defense reporting. This is the most concrete real-world example of a DARPA-funded injectable nano-biosensor at human deployment.
Policy & Regulatory
World Economic Forum white paper defining three-tier IoB architecture. Key findings: HIPAA does not cover consumer wearables; body is "a new data platform"; military and law enforcement interest in IoB data acknowledged; governance gap identified. weforum.org/reports/shaping-the-future-of-the-internet-of-bodies
RAND companion report to the WEF IoB paper. Covers same three-tier framework with independent analysis of governance, security, and risk. rand.org/pubs/research_reports/RRA1482-1.html
Effective January 22, 2024. Allows "minimal risk" clinical investigations without obtaining informed consent from subjects. IRB determines "minimal risk" — not the subject. Federal Register, 2024.
Mandates FHIR data standards across Medicare and Medicaid. Requires health data systems to support standardized API access. HHS ONC Final Rule, effective 2021. healthit.gov
National Nanotechnology Initiative strategic plan covering nano-scale health monitoring applications across NIH, NSF, DoD, FDA, and NIST. nano.gov/sites/default/files/pub_resource/nni_strategic_plan_2021.pdf
Investigative Analysis
Substack investigative analysis synthesizing the WBAN technical infrastructure, biofield research, DARPA programs, and the commercial data layer. Draws on primary source documentation throughout. tatsuikeda.substack.com
Note on LifeWave/DARPA: No publicly accessible DARPA contract record naming David Schmidt or LifeWave appears in any verified government database. Claims about military origins in LifeWave promotional content cannot be verified from primary sources. The DARPA photobiomodulation programs (BETR) are real and documented; the direct connection to LifeWave is not established. Treat promotional claims about government origins as unverified until a primary source document is produced.
Ready to go deeper?
Fellowship opens the door to personal ministry support from Rev. Dr. Allie — applied to your specific path.
Enter into Fellowship